Gilead Sciences | 营业利润



Operating Profit 更改 日
AbbVie USD 3.73B 5.22B 2025-03
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
ALKERMES USD 162.69M 57.93M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Incyte USD 205.17M 96.34M 2025-03
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Gilead Sciences 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.